Arcutis (ARQT) Price Chart

Corporate emblem and logo of arcutis.com (ARQT)

The current market value of Arcutis Biotherapeutics (ARQT) shown on this chart is 27.13, reflecting the company's transition to stable liquidity. The successful commercialization of psoriasis treatments has halted the cash burn and strengthened the balance sheet. Growth in Zoryve prescriptions, expanded insurance coverage, and new indications for dermatitis treatment are driving development. The business potential is supported by large-scale R&D investments in the creation of innovative ointments to combat eczema.

Price Rate Chart: arcutis.com (ARQT) for 07/04/2022 - 11/17/2026

Arcutis Biotherapeutics Inc - analytical breakdowns and key metrics (ARQT)

Fundamental valuation:arcutis.com
Signature product of Arcutis

Professional selection of resilient assets begins with an analysis of the market valuation consensus. Price captures the final equilibrium of supply and demand at the close of the trading session, reflecting the current capitalization of the business. By studying an asset's price trajectory, an investor determines the vector of market expectations. For Arcutis Biotherapeutics (ARQT), this indicator is stabilizing due to its operations in the solvent US market. Minimal geopolitical risks within the dermatology sector provide a reliable foundation for the quotes.